Acute Post-Radiation Hyperbaric Oxygen (HBO2) for Breast Cancer Patients Who Have Recently Completed Radiation Therapy
Status:
Recruiting
Trial end date:
2024-05-01
Target enrollment:
Participant gender:
Summary
This study aims to compare patients that receive hyperbaric oxygen or Trental and Vitamin E
immediately after completion of radiation therapy to evaluate which treatment best reduces
radiation fibrosis.
Phase:
Phase 2
Details
Lead Sponsor:
Legacy Health System
Treatments:
alpha-Tocopherol Pentoxifylline Tocopherols Tocotrienols Vitamin E Vitamins